Literature DB >> 18193036

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.

Qihong Huang1, Kiranmai Gumireddy, Mariette Schrier, Carlos le Sage, Remco Nagel, Suresh Nair, David A Egan, Anping Li, Guanghua Huang, Andres J Klein-Szanto, Phyllis A Gimotty, Dionyssios Katsaros, George Coukos, Lin Zhang, Ellen Puré, Reuven Agami.   

Abstract

MicroRNAs (miRNAs) are single-stranded, noncoding RNAs that are important in many biological processes. Although the oncogenic and tumour-suppressive functions of several miRNAs have been characterized, the role of miRNAs in mediating tumour metastasis was addressed only recently and still remains largely unexplored. To identify potential metastasis-promoting miRNAs, we set up a genetic screen using a non-metastatic, human breast tumour cell line that was transduced with a miRNA-expression library and subjected to a trans-well migration assay. We found that human miR-373 and miR-520c stimulated cancer cell migration and invasion in vitro and in vivo, and that certain cancer cell lines depend on endogenous miR-373 activity to migrate efficiently. Mechanistically, the migration phenotype of miR-373 and miR-520c can be explained by suppression of CD44. We found significant upregulation of miR-373 in clinical breast cancer metastasis samples that correlated inversely with CD44 expression. Taken together, our findings indicate that miRNAs are involved in tumour migration and invasion, and implicate miR-373 and miR-520c as metastasis-promoting miRNAs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193036     DOI: 10.1038/ncb1681

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  421 in total

1.  MicroRNAs used as novel biomarkers for detecting cancer metastasis.

Authors:  Chunshan Han; Haixiang Yu; Lening Zhang; Xiaoli Li; Yonggang Feng; Hua Xin
Journal:  Tumour Biol       Date:  2014-10-31

Review 2.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

3.  miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.

Authors:  Mian Ling Chen; Liu Sen Liang; Xiao Kang Wang
Journal:  Clin Exp Metastasis       Date:  2012-03-10       Impact factor: 5.150

4.  Genome-wide screen for miRNA targets using the MISSION target ID library.

Authors:  Matthew J Coussens; Kevin Forbes; Carol Kreader; Jack Sago; Carrie Cupp; John Swarthout
Journal:  J Vis Exp       Date:  2012-04-06       Impact factor: 1.355

5.  MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII.

Authors:  Xiaofeng Jiang; Guangyang Xiang; Yezeng Wang; Lei Zhang; Xuewei Yang; Liangqi Cao; Heping Peng; Ping Xue; De Chen
Journal:  Mol Cells       Date:  2012-06-07       Impact factor: 5.034

6.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition.

Authors:  Kazuhiro Yachi; Masumi Tsuda; Shinji Kohsaka; Lei Wang; Yoshitaka Oda; Satoshi Tanikawa; Yusuke Ohba; Shinya Tanaka
Journal:  Signal Transduct Target Ther       Date:  2018-12-28

Review 8.  Rheostatic signaling by CD44 and hyaluronan.

Authors:  Ellen Puré; Richard K Assoian
Journal:  Cell Signal       Date:  2009-01-13       Impact factor: 4.315

Review 9.  Review: placenta-specific microRNAs in exosomes - good things come in nano-packages.

Authors:  Y Ouyang; J-F Mouillet; C B Coyne; Y Sadovsky
Journal:  Placenta       Date:  2013-11-15       Impact factor: 3.481

10.  A simple high-throughput technology enables gain-of-function screening of human microRNAs.

Authors:  Wen-Chih Cheng; Tami J Kingsbury; Sarah J Wheelan; Curt I Civin
Journal:  Biotechniques       Date:  2013-02       Impact factor: 1.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.